122 related articles for article (PubMed ID: 19474756)
21. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic.
Fletcher FE; Vidrine DJ; Tami-Maury I; Danysh HE; King RM; Buchberg M; Arduino RC; Gritz ER
AIDS Behav; 2014 Mar; 18(3):544-54. PubMed ID: 23605155
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
24. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
25. Timely reminder interventions to improve annual Papanicolaou (Pap) smear rates among HIV-infected women in an outpatient center of southern Nevada: a short report.
Ganta V; Moonie S; Patel D; Hunt AT; Richardson J; Di John D; Ezeanolue EE
AIDS Care; 2017 Sep; 29(9):1099-1101. PubMed ID: 28460538
[TBL] [Abstract][Full Text] [Related]
26. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
27. [Knowledge and use of Pap-smear among HIV-positive women].
Pavia C; Navarra A; Pisani G; Piselli P; Koehler B; Angeletti C; Ippolito G; Serraino D
Minerva Ginecol; 2006 Jun; 58(3):233-8. PubMed ID: 16783295
[TBL] [Abstract][Full Text] [Related]
28. Declining prevalence of cytological squamous intraepithelial lesions of the cervix among women living with well-controlled HIV - Most women living with HIV do not need annual PAP smear screening.
Aho I; Kivelä P; Haukka J; Sutinen J; Heikinheimo O
Acta Obstet Gynecol Scand; 2017 Nov; 96(11):1330-1337. PubMed ID: 28832899
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
30. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
Guo F; Hirth JM; Berenson AB
Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Pap smear screening in socioeconomically disadvantaged elderly women.
Weinrich S; Coker AL; Weinrich M; Eleazer GP; Greene FL
J Am Geriatr Soc; 1995 Mar; 43(3):267-70. PubMed ID: 7884116
[TBL] [Abstract][Full Text] [Related]
34. Progression and regression of cervical pap test lesions in an urban AIDS clinic in the combined antiretroviral therapy era: a longitudinal, retrospective study.
Lofgren SM; Tadros T; Herring-Bailey G; Birdsong G; Mosunjac M; Flowers L; Nguyen ML
AIDS Res Hum Retroviruses; 2015 May; 31(5):508-13. PubMed ID: 25693769
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
36. Annual colposcopies and pap smears recommended for women with HIV.
Highleyman L
BETA; 1999 Apr; 12(2):6. PubMed ID: 11366700
[TBL] [Abstract][Full Text] [Related]
37. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
Tron L; Lert F; Spire B; Dray-Spira R;
HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
[TBL] [Abstract][Full Text] [Related]
38. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
39. How Is Health Literacy Related to Pap Testing Among US Women?
Thompson EL; Wheldon CW; Vamos CA; Griner SB; Daley EM
J Cancer Educ; 2019 Aug; 34(4):789-795. PubMed ID: 29931455
[TBL] [Abstract][Full Text] [Related]
40. Cancer screening in women: body mass index and adherence to physician recommendations.
Ferrante JM; Chen PH; Crabtree BF; Wartenberg D
Am J Prev Med; 2007 Jun; 32(6):525-31. PubMed ID: 17533069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
